ARVO 2017 awards in spotlightAs eye and vision researchers gather this month for the 2017 meeting of the Association for Research in Vision and Ophthalmology (ARVO), four members will be recognized for their contributions to ophthalmology and vision research with a 2017 ARVO Achievement Award and lecture.
In this issue
Managing antithrombotic agents in patients scheduled for eyelid surgeryPerioperative antithrombotic therapy in eyelid surgery lacks comprehensive guidelines and new studies to address these limitations are warranted, especially in the context of new oral anticoagulants.
DSEK or DMEK? Choosing the best for patients with corneal edema May 01, 2017By Lynda ChartersCareful consideration must be given to the timing and choice of surgery in eyes with corneal edema.
Sustained-release insert aids patient noncomplianceThe current convention for treating pain and inflammation in postsurgical cataract patients is confusing, inconvenient, and expensive. Patient compliance with a self-administereddrop regimen is poor. Multiple studies confirm that the vast majority of patients fail to instill the
drops properly or administer the drops as prescribed.
Presbyopic IOLs changing game for astigmatic patientsPresbyopia-correcting IOLs are changing the preoperative patient education discussion, making it easier for surgeons. However, the need for precision measurements and careful surgical technique may be more important than in the past.
The Retinator II: Judgment Day? May 01, 2017By Ian C. Han MDHollywood loves trilogies, and though not all sequels are created equal, as a general rule, the second installment tends to be the best. The examples of this phenomenon are numerous (Godfather Part II, Back to the Future II, The Empire Strikes Back, etc.). However, the most-cultured Ophthalmology Times readers will no doubt point to Terminator II as the best example of all.